Altimmune (ALT) Preferred Dividend Payments (2016 - 2019)
Altimmune (ALT) reported Preferred Dividend Payments of $452925.0 for Q1 2019, down 76.05% year-over-year from $1.9 million in Q1 2018, and down 41.97% quarter-over-quarter from $780525.0 in Q4 2018.
Altimmune (ALT) Preferred Dividend Payments (2016 - 2019) Analysis & Trends
Altimmune (ALT) has 4 years of Preferred Dividend Payments data on file, last reported at $452925.0 in Q1 2019.
- Preferred Dividend Payments for Q1 2019 came in at $452925.0, down 76.05% year-over-year; the trailing twelve-month figure through Dec 2019 was $452925.0 (down 86.31% YoY), and the FY2019 annual result was $452925.0, down 86.31% from the prior year.
- Preferred Dividend Payments eased to $452925.0 in Q1 2019 per ALT's latest filing, from $780525.0 in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $2.8 million in Q4 2017 and troughed at -$64139.0 in Q3 2018.
- A 4-year average of $750282.7 and a median of $286955.5 in 2016 frame the typical range for Preferred Dividend Payments.
- The sharpest annual moves came in 2017 and 2018: Preferred Dividend Payments soared 2218.34% in 2017, then tumbled 103.27% in 2018.
- A 4-year view of Preferred Dividend Payments shows it stood at $120986.0 in 2016, then soared by 2218.34% to $2.8 million in 2017, then sank by 72.17% to $780525.0 in 2018, then tumbled by 41.97% to $452925.0 in 2019.
- Business Quant data shows ALT's Preferred Dividend Payments at $452925.0 in Q1 2019, $780525.0 in Q4 2018, and -$64139.0 in Q3 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 452,925.00 |
| Dec 31, 2018 | 780,525.00 |
| Sep 30, 2018 | -64,139.00 |
| Jun 30, 2018 | 700,093.00 |
| Mar 31, 2018 | 1.89 Mn |
| Dec 31, 2017 | 2.80 Mn |
| Sep 30, 2017 | 1.96 Mn |
| Jun 30, 2017 | 44,713.00 |
| Mar 31, 2017 | 118,356.00 |
| Dec 31, 2016 | 120,986.00 |
| Sep 30, 2016 | 104,548.00 |
| Jun 30, 2016 | 87,123.00 |